[IOICORP] QoQ TTM Result on 31-Dec-2011 [#2]

Announcement Date
23-Feb-2012
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2012
Quarter
31-Dec-2011 [#2]
Profit Trend
QoQ- 2.9%
YoY- -3.5%
Quarter Report
View:
Show?
TTM Result
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Revenue 14,285,400 15,300,400 16,217,045 16,978,004 16,782,591 16,154,251 14,889,944 -2.71%
PBT 2,214,700 2,056,500 2,581,978 2,703,442 2,625,966 2,863,612 2,749,942 -13.40%
Tax -45,200 -227,900 -614,091 -614,349 -575,242 -573,099 -472,232 -78.98%
NP 2,169,500 1,828,600 1,967,887 2,089,093 2,050,724 2,290,513 2,277,710 -3.18%
-
NP to SH 2,135,600 1,789,400 1,935,623 2,040,333 1,982,871 2,222,899 2,222,126 -2.60%
-
Tax Rate 2.04% 11.08% 23.78% 22.72% 21.91% 20.01% 17.17% -
Total Cost 12,115,900 13,471,800 14,249,158 14,888,911 14,731,867 13,863,738 12,612,234 -2.63%
-
Net Worth 12,610,922 12,659,756 12,208,616 12,144,648 11,620,739 11,995,655 11,340,260 7.31%
Dividend
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Div 996,034 996,034 1,027,132 1,027,132 1,087,994 1,087,994 1,148,994 -9.06%
Div Payout % 46.64% 55.66% 53.06% 50.34% 54.87% 48.94% 51.71% -
Equity
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Net Worth 12,610,922 12,659,756 12,208,616 12,144,648 11,620,739 11,995,655 11,340,260 7.31%
NOSH 6,401,483 6,426,272 6,425,587 6,425,739 6,420,298 6,414,789 6,406,926 -0.05%
Ratio Analysis
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
NP Margin 15.19% 11.95% 12.13% 12.30% 12.22% 14.18% 15.30% -
ROE 16.93% 14.13% 15.85% 16.80% 17.06% 18.53% 19.60% -
Per Share
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 223.16 238.09 252.38 264.22 261.40 251.83 232.40 -2.66%
EPS 33.36 27.85 30.12 31.75 30.88 34.65 34.68 -2.54%
DPS 15.50 15.50 16.00 16.00 17.00 17.00 18.00 -9.46%
NAPS 1.97 1.97 1.90 1.89 1.81 1.87 1.77 7.37%
Adjusted Per Share Value based on latest NOSH - 6,425,739
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 230.35 246.72 261.50 273.77 270.62 260.49 240.10 -2.71%
EPS 34.44 28.85 31.21 32.90 31.97 35.84 35.83 -2.59%
DPS 16.06 16.06 16.56 16.56 17.54 17.54 18.53 -9.07%
NAPS 2.0335 2.0414 1.9686 1.9583 1.8738 1.9343 1.8286 7.31%
Price Multiplier on Financial Quarter End Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 -
Price 4.98 5.19 5.34 5.38 4.65 5.30 5.76 -
P/RPS 2.23 2.18 2.12 2.04 1.78 2.10 2.48 -6.82%
P/EPS 14.93 18.64 17.73 16.94 15.06 15.29 16.61 -6.84%
EY 6.70 5.37 5.64 5.90 6.64 6.54 6.02 7.37%
DY 3.11 2.99 3.00 2.97 3.66 3.21 3.13 -0.42%
P/NAPS 2.53 2.63 2.81 2.85 2.57 2.83 3.25 -15.33%
Price Multiplier on Announcement Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 19/11/12 27/08/12 30/05/12 23/02/12 18/11/11 24/08/11 16/05/11 -
Price 4.93 5.12 5.23 5.33 5.06 4.67 5.19 -
P/RPS 2.21 2.15 2.07 2.02 1.94 1.85 2.23 -0.59%
P/EPS 14.78 18.39 17.36 16.79 16.38 13.48 14.96 -0.80%
EY 6.77 5.44 5.76 5.96 6.10 7.42 6.68 0.89%
DY 3.14 3.03 3.06 3.00 3.36 3.64 3.47 -6.42%
P/NAPS 2.50 2.60 2.75 2.82 2.80 2.50 2.93 -10.01%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment